skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines rimegepantQuestion & answer

rimegepant · Medicine question

Which receptor does rimegepant block?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Rimegepant selectively binds with high affinity to the human calcitonin gene-related peptide (CGRP) receptor and blocks its function.

Sources for this answer

VYDURA 75 mg oral lyophilisatePfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated 10 March 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

rimegepant

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about rimegepant

Does Vydura (rimegepant) affect the ability to drive or use machines?What does the Vydura (rimegepant) oral lyophilisate look like?What excipients are in Vydura (rimegepant) oral lyophilisates?What have animal studies shown about rimegepant's effects on fertility?What is the elimination half-life of rimegepant in healthy people?Which enzymes metabolise rimegepant?

Read the rimegepant guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX